Britain wants to see more investment in the country by pharmaceutical companies if it agrees to pay higher drug prices as ...

Dermatology is thriving with innovation, from smart oral drugs to gene-therapy based fixes for rare skin diseases and skin ...

Pharmaceutical giant Merck & Co. is breaking ground on a $3 billion expansion of its longtime Elkton manufacturing campus, a ...

If you are on the fence about what to do with your GSK shares, you are not alone. The stock has seen some interesting moves ...

Medicus Pharma has carved out a niche in dermatological therapeutics, focusing on novel compounds and delivery systems ...

Latest analysis of U.S. real-world evidence demonstrates improved clinical outcomes when cefiderocol is used as earlier ...

Danaher recorded higher third-quarter sales and profit on the back of momentum in its bioprocessing business and better-than-expected sales in its respiratory market. The life sciences and diagnostics ...

Sharon Lock, a former pharmaceutical scientist, has been appointed principal of Layfield Primary School in Yarm.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

President Donald Trump announced this on Thursday, along with new federal guidance encouraging employers to offer fertility ...

On Oct. 1, Pfizer agreed to lower the prices of some drugs in response to President Donald Trump’s executive order on most favored nation drug pricing.

SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), announced that its clinical lead drug NV-387 has shown strong ...